As of May 31, 2025, Isracann Biosciences Inc (IPOT.CN) reports a ROA (Return on Assets) of -114.73%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Isracann Biosciences Inc's ROA (Return on Assets)
Over recent years, Isracann Biosciences Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2022-05-31 | -114.73% |
| 2021-05-31 | -571.65% |
| 2020-05-31 | -85.60% |
| 2019-05-31 | -60.49% |
| 2018-05-31 | -51.35% |
This slight downward trend highlights how Isracann Biosciences Inc manages its efficiency in using assets to generate earnings over time.
Comparing Isracann Biosciences Inc's ROA (Return on Assets) to Peers
To better understand Isracann Biosciences Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Isracann Biosciences Inc (IPOT.CN) | -114.73% |
| Seedo Corp (SEDO) | 1828.23% |
| Ether Capital Corp (ETHC.NE) | 43.90% |
| CYIOS Corp (CYIO) | 25.78% |
| BYT Holdings Ltd (BYT.CN) | -8.01% |
| iMining Technologies Inc (IMIN.V) | -14.49% |
Compared to its competitors, Isracann Biosciences Inc's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.